During the past decade, Cancer Institute Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Institute Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 7 trials as a collaborator, "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Yakult Honsha Co., LTD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Institute Hospital" are "Gastric Neoplasm" (2 trials), "Gastric Cancer" (1 trials), "Malignant Pericardial Effusion" (1 trials), "Small-Cell-Lung Cancer" (1 trials) and "T1N0M0 Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Cancer Institute Hospital" in a lesser frequency.

Most popular intervention types in "Cancer Institute Hospital" are "Drug" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Etoposide and cisplatin after chemoradiotherapy" (1 trials), "Gastrectomy with more than D2 dissection" (1 trials), "Irinotecan and cisplatin after chemoradiotherapy" (1 trials), "Neoadjuvant chemotherapy(TS-1+CDDP) followed by gastrectomy" (1 trials) and "Observation alone after pericardial drainage" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Institute Hospital" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Institute Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Cancer Institute Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Institute Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".